Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of ...
Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.
Zacks Investment Research on MSN
ImmunityBio shares surge on updated durable lymphoma study results
Shares of ImmunityBio IBRX surged 39.8% on Friday and added a further 9.4% in after-hours trading after the company reported ...
Teens with advanced-stage Hodgkin lymphoma survive longer without their disease getting worse when they receive the ...
Incyte (INCY) stock and Xencor (XNCR) stock are in focus as jointly developed antibody drug tafasitamab succeeds in a late-stage trial for lymphoma. Read more here.
A 25-year-old woman who said a GP “laughed” at her when she suggested she might have cancer later discovered she had Hodgkin ...
Dr. Ian Flinn, chief scientific officer at Tennessee Oncology and One Oncology in Nashville, Tennessee, explains Lunsumio ...
Jack Rivers is known to the Bayside community as a kind, good-natured teen with a heart of gold. An active member of many ...
Despite the late-stage miss, analysts maintained confidence in the Epkinly program, with Truist Securities saying the result ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results